SAN CARLOS, Calif.-- October 14, 2026 -- Altay Therapeutics, Inc., a biotechnology company developing novel small molecule inhibitors of transcription factors, today announced the completion of a $37 million Series...
Eric Linsley to speak at CED's Biotech Forum: "How Early is Too Early?" in RTP, NC
News | 04. 28. 2008
